Impact of transdermal oxybutynin on depression symptoms in patients with overactive bladder - Results of the MATRIX study

被引：3
|
作者：
Sand, Peter K. [1 ]
Lucente, Vincent R. [1 ]
Parker, Robert Lamar [1 ]
Goldberg, Roger P. [1 ]
Dahl, Naomi V. [1 ]
机构：
[1] Northwestern Univ, Evanston, IL USA
来源：
OBSTETRICS AND GYNECOLOGY | 2006年 / 107卷 / 04期
关键词：
D O I：
10.1097/00006250-200604001-00182
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：76S / 76S
页数：1
相关论文
共 50 条
  • [31] Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials
    Roger R. Dmochowski
    Victor Nitti
    David Staskin
    Karl Luber
    Rodney Appell
    G. Willy Davila
    World Journal of Urology, 2005, 23 : 263 - 270
  • [32] The impact of the overactive bladder syndrome on sexual function: A preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial
    Sand, Peter K.
    Goldberg, Roger P.
    Dmochowski, Roger R.
    McIlwain, Marilyn
    Dahl, Naomi V.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : 1730 - 1735
  • [33] Transdermal delivery of oxybutynin chloride proniosomal gels for the treatment of overactive bladder
    Rajabalaya, Rajan
    David, Sheba R.
    Chellian, Jestin
    Yun, Gwee Xin
    Chakravarthi, Srikumar
    DRUG DELIVERY, 2016, 23 (05) : 1578 - 1587
  • [34] Oxybutynin nanosuspension gel for enhanced transdermal treatment for overactive bladder syndrome
    Sheng, Yuze
    Zhang, Shuang
    Ling, Jiawei
    Hu, Chenlu
    Zhang, Zhenhai
    Lv, Huixia
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2022, 27 (04) : 459 - 468
  • [35] Effectiveness and safety of transdermal oxybutynin for overactive bladder in adults previously treated with orally administered oxybutynin
    Dmochowski, Roger R.
    Dahl, Naomi V.
    NEUROUROLOGY AND URODYNAMICS, 2008, 27 (02) : 131 - 132
  • [36] Transdermal oxybutynin treatment for overactive bladder in women receiving estrogen therapy
    Davila, G. Willy
    Dahl, Naomi V.
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 112S - 112S
  • [37] Anticholinergic and other adverse events with transdermal oxybutynin for overactive bladder in patients ≥70 years.
    Dmochowski, RR
    Davila, GW
    Sanders, SW
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S39 - S39
  • [38] TOLERABILITY OF SOLIFENACIN IN COMPARISON WITH OXYBUTYNIN IMMEDIATE RELEASE IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS OF THE VECTOR STUDY
    Herschorn, Sender
    Pommerville, Peter
    Stothers, Lynn
    Egerdie, Blair
    Gajewski, Jerzy
    Carlson, Kevin
    Radomski, Sidney
    Drutz, Harold
    Schulz, Jane
    Barkin, Jack
    Hirshberg, Eric
    Corcos, Jacques
    JOURNAL OF UROLOGY, 2009, 181 (04): : 557 - 557
  • [39] Impact of overactive bladder on quality of life in older patients: Interim results of the matrix study.
    Dmochowski, RR
    Reaves, LA
    Hale, DS
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S160 - S161
  • [40] Transdermal matrix plaster - More quality of life in patients with overactive bladder
    不详
    UROLOGE, 2007, 46 (03): : 346 - 346
12345